FMP
Enter
Data
Fundamental StatementsForm 13FInsider & Congressional TradingAnalyst Estimates & Price TargetHistorical Market DataReal-Time WebSocketESG DataForex Market DataETF & Mutual FundCommodity Market DataIndex Market DataAdvanced Market MetricsEconomics DataSearch & DirectoryCrypto DataEarnings Call TranscriptsMarket CalendarCompany Profile
API Tools
Extras
BiondVax Pharmaceuticals Ltd.
BVXV
NASDAQ
Inactive Equity
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
1.36 USD
0.01 (0.735%)
